Pyrogastrone for oesophagitis.
D000464:Alginates / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002229:Carbenoxolone / Q000627:therapeutic use*; D004338:Drug Combinations; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D017640:Silicates; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D017640:Silicates; D012824:Silicic Acid; D000536:Aluminum Hydroxide; D012822:Silicon Dioxide; C021080:pyrogastrone; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid